UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021741
Receipt number R000024838
Scientific Title Acoustic analysis of swallowing sound for assessment of dysphagia in patients with neuromuscular disorders
Date of disclosure of the study information 2016/05/01
Last modified on 2022/12/20 09:20:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Acoustic analysis of swallowing sound for assessment of dysphagia in patients with neuromuscular disorders

Acronym

Acoustic analysis in patients with neuromuscular disorders

Scientific Title

Acoustic analysis of swallowing sound for assessment of dysphagia in patients with neuromuscular disorders

Scientific Title:Acronym

Acoustic analysis in patients with neuromuscular disorders

Region

Japan


Condition

Condition

Neuromuscular disorders

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To evaluate the efficacy of acoustic analysis of swallowing by auscultation

Basic objectives2

Others

Basic objectives -Others

no additional objects

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlation of Swallowing contrast imaging and swallowing sound (0M 6M 12M ...)

Key secondary outcomes

Clinical outcome measurements including ALSFRS-R, SBMAFRS, and so on.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Videofluoroscopic swallowing study and acoustic analysis of swallowing

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who meet the diagnostic criteria of neuromuscular diseases (Amyotrophic lateral sclerosis, spinal and bulbar muscular atrophy, et al.)
1) Patients who are 20 years old and over
2) Patients who are able to return to periodic follow-up visit
3) Patiets who gave written informed consent

Key exclusion criteria

1) Patients who have severe complications

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Masahisa
Middle name
Last name Katsuno

Organization

Nagoya University Graduate school of Medicine

Division name

Department of Neurology

Zip code

4668550

Address

Tsurumai-cho 65, Showa-ku, Nagoya city, Aichi

TEL

052-744-2390

Email

ka2no@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Atsushi
Middle name
Last name Hashizume

Organization

Nagoya University Graduate school of Medicine

Division name

Department of Neurology

Zip code

4668550

Address

Tsurumai-cho 65, Showa-ku, Nagoya city, Aichi

TEL

052-744-2390

Homepage URL


Email

hassy0707@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Graduate school of Medicine

Institute

Department

Personal name



Funding Source

Organization

KAKENHI

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

National Center for geriatrics and gerontology
Aichi Gakuin University, Department of Health Science

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University hospital ethics committee

Address

Tsurumaicho 65, Showa ward, Nagoya city, Aichi prefecture

Tel

052-744-2479

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 05 Month 01 Day


Related information

URL releasing protocol

None

Publication of results

Published


Result

URL related to results and publications

https://www.jstage.jst.go.jp/article/internalmedicine/56/23/56_8799-16/_article

Number of participants that the trial has enrolled

111

Results

Our results showed that the pharyngeal barium residue after initial swallowing correlated better
with the bulbar-related functional rating scales than that after multiple deglutition. This correlation was vague
when the data from patients whose barium residue was >50% were eliminated. In addition, evaluating the
pharyngeal residue after initial swallowing proved to be the most sensitive method with regard to laryngeal
penetration.

Results date posted

2022 Year 12 Month 20 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2017 Year 10 Month 11 Day

Baseline Characteristics

The mean age of the 111 SBMA patients was 53.2 (10.4) years, duration of disease was 11.0 (8.0) years, and age of onset was 42.2 (11.8) years. The ALSFRS-R score at the first visit was 10.6 (1.5).

Participant flow

All patients with SBMA underwent Videofluoroscopic Swallowing Study at Nagoya University Hospital. We also evaluated the patients' background and physical function during the VFSS. None of the subjects had undergone treatment with leuprorelin acetate or other similar drugs at the time of the VFSS.

Adverse events

No adverse events were reported.

Outcome measures

Pharyngeal barium residue and penetration score evaluated by the Videofluoroscopic Swallowing Study (VFSS)

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2016 Year 03 Month 18 Day

Date of IRB

2019 Year 03 Month 12 Day

Anticipated trial start date

2016 Year 05 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 04 Month 01 Day

Last modified on

2022 Year 12 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024838


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name